1. Home
  2. NAII vs DYAI Comparison

NAII vs DYAI Comparison

Compare NAII & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Alternatives International Inc.

NAII

Natural Alternatives International Inc.

N/A

Current Price

$1.17

Market Cap

15.8M

Sector

Health Care

ML Signal

N/A

Logo Dyadic International Inc.

DYAI

Dyadic International Inc.

HOLD

Current Price

$0.42

Market Cap

17.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAII
DYAI
Founded
1980
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.8M
17.0M
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
NAII
DYAI
Price
$1.17
$0.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
27.3K
★ 150.1K
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $132,437,000.00
$3,090,345.00
Revenue This Year
N/A
$113.16
Revenue Next Year
N/A
$94.92
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 8.60
N/A
52 Week Low
$1.11
$0.34
52 Week High
$4.96
$1.60

Technical Indicators

Market Signals
Indicator
NAII
DYAI
Relative Strength Index (RSI) 19.21 33.80
Support Level N/A $0.34
Resistance Level $2.83 $0.50
Average True Range (ATR) 0.19 0.04
MACD -0.03 0.01
Stochastic Oscillator 7.26 10.10

Price Performance

Historical Comparison
NAII
DYAI

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About DYAI Dyadic International Inc.

Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Share on Social Networks: